Transient Receptor Potential Vanilloid 4-Dependent Microglial Function in Myelin Injury and Repair

Jameson P Holloman1, Sophia H Dimas2, Angela S Archambault1

  • 1Department of Neurology, Washington University School of Medicine, Saint Louis, MO 63110, USA.

Insights

Transient receptor potential vanilloid 4 (TRPV4) deletion enhances microglial phagocytosis but does not affect multiple sclerosis (MS) disease severity or demyelination in mouse models. TRPV4 appears to have a limited role in MS pathogenesis.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Neuroscience

Background:

  • Microglia play dual roles in multiple sclerosis (MS) pathogenesis, contributing to both inflammation and neuroprotection.
  • Transient receptor potential vanilloid 4 (TRPV4) channels are involved in cellular sensing, calcium homeostasis, and modulate myeloid cell functions.
  • TRPV4 influences microglial motility and phagocytosis, suggesting a potential role in MS.

Purpose of the Study:

  • To investigate the role of TRPV4 in microglial phagocytosis and its impact on demyelination and disease activity in MS models.
  • To determine if genetic deletion of TRPV4 affects disease progression in experimental autoimmune encephalitis (EAE) and cuprizone-induced demyelination models.
  • To assess TRPV4 expression in MS brain tissue.

Main Methods:

  • In vitro assessment of microglial phagocytosis following TRPV4 deletion.
  • Evaluation of demyelination and remyelination in the cuprizone mouse model with TRPV4 deletion.
  • Assessment of disease severity in the EAE model with global and microglia-specific TRPV4 deletion.
  • Analysis of TRPV4 expression in human MS brain tissue.

Main Results:

  • Genetic deletion of TRPV4 increased microglial phagocytosis in vitro.
  • TRPV4 deletion did not alter demyelination or remyelination in the cuprizone model.
  • No significant differences in disease severity were observed in EAE models with TRPV4 deletion.
  • TRPV4 expression levels were similar in lesioned, normal-appearing white matter, and healthy brain tissue from MS patients.

Conclusions:

  • TRPV4 modulates microglial phagocytic activity in vitro.
  • TRPV4 does not significantly impact disease activity or demyelination in experimental models of MS.
  • These findings suggest a muted or redundant role for TRPV4 in the pathogenesis of MS.

Related Concept Videos